financetom
Business
financetom
/
Business
/
NHTSA opens probe into over 2 million Honda vehicles over engine restarting concerns
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NHTSA opens probe into over 2 million Honda vehicles over engine restarting concerns
Mar 28, 2025 2:33 AM

(Reuters) - The National Highway Traffic Safety Administration said on Friday that it was opening an engineering analysis into about 2.2 million Honda ( HMC ) vehicles over concerns related to its engine restarting.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
AstraZeneca Says DATROWAY Shows Promising Results in Combination Trials for Lung Cancer
AstraZeneca Says DATROWAY Shows Promising Results in Combination Trials for Lung Cancer
Jun 2, 2025
07:01 AM EDT, 06/02/2025 (MT Newswires) -- AstraZeneca ( AZN ) said Sunday that DATROWAY, a TROP2-directed antibody drug conjugate, showed promising efficacy and safety in early and advanced non-small cell lung cancer across multiple trials. In the TROPION-Lung02 trial, 96 patients received DATROWAY with pembrolizumab, with or without platinum chemo, showing response rates over 54% and disease control rates...
AstraZeneca, Daiichi Sankyo's Gastric Cancer Phase 3 Trial Shows 'Statistically Significant' Improvement in Overall Survival
AstraZeneca, Daiichi Sankyo's Gastric Cancer Phase 3 Trial Shows 'Statistically Significant' Improvement in Overall Survival
Jun 2, 2025
06:59 AM EDT, 06/02/2025 (MT Newswires) -- AstraZeneca ( AZN ) and Daiichi Sankyo's Enhertu treatment showed a statistically significant and clinically meaningful improvement in overall survival, compared with ramucirumab plus paclitaxel in patients with second-line HER2 positive unresectable and/or metastatic gastric or gastroesophageal junction adenocarcinoma, Daiichi Sankyo said Saturday. Based on the results from a phase 3 trial, Enhertu...
Market Chatter: Meta to Use AI for Fully Automated Ad Generation
Market Chatter: Meta to Use AI for Fully Automated Ad Generation
Jun 2, 2025
07:01 AM EDT, 06/02/2025 (MT Newswires) -- Meta Platforms ( META ) plans to use artificial intelligence for full automation of advertisement creation and targeting by the end of 2026, the Wall Street Journal reported Monday, citing people familiar with the matter. While Meta's ad platform already employs some AI tools, the company now plans to help advertisers build ad...
Copyright 2023-2026 - www.financetom.com All Rights Reserved